The induced hypoglycemia in EAC-untreated mice may be a result of glucose utilization by tumor cells that overproduce partially processed insulin-like growth factor-2 (IGF-2), which stimulates insulin receptors [62]. The gene discussed is IGF2; the disease is Hypoglycemia.